These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 22410638)
1. Glycemic control after stomach-sparing duodenal-jejunal bypass surgery in diabetic patients with low body mass index. Cohen R; Caravatto PP; Correa JL; Noujaim P; Petry TZ; Salles JE; Schiavon CA Surg Obes Relat Dis; 2012; 8(4):375-80. PubMed ID: 22410638 [TBL] [Abstract][Full Text] [Related]
2. Metabolic surgery for non-obese type 2 diabetes: incretins, adipocytokines, and insulin secretion/resistance changes in a 1-year interventional clinical controlled study. Geloneze B; Geloneze SR; Chaim E; Hirsch FF; Felici AC; Lambert G; Tambascia MA; Pareja JC Ann Surg; 2012 Jul; 256(1):72-8. PubMed ID: 22664560 [TBL] [Abstract][Full Text] [Related]
3. Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Lee WJ; Almulaifi AM; Tsou JJ; Ser KH; Lee YC; Chen SC Surg Obes Relat Dis; 2015; 11(4):765-70. PubMed ID: 25813754 [TBL] [Abstract][Full Text] [Related]
4. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. Zervos EE; Agle SC; Warren AJ; Lang CG; Fitzgerald TL; Dar M; Rotondo MF; Pories WJ J Am Coll Surg; 2010 May; 210(5):564-72, 572-4. PubMed ID: 20421005 [TBL] [Abstract][Full Text] [Related]
5. Duodenal-jejunal bypass attenuates progressive failure of pancreatic islets in streptozotocin-induced diabetic rats. Wang T; Zhang P; Zhang X; Cao T; Zheng C; Yu B Surg Obes Relat Dis; 2017 Feb; 13(2):250-260. PubMed ID: 27865809 [TBL] [Abstract][Full Text] [Related]
6. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Hamza N; Abbas MH; Darwish A; Shafeek Z; New J; Ammori BJ Surg Obes Relat Dis; 2011; 7(6):691-6. PubMed ID: 20688578 [TBL] [Abstract][Full Text] [Related]
7. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061 [TBL] [Abstract][Full Text] [Related]
8. A high-fat diet reverses improvement in glucose tolerance induced by duodenal-jejunal bypass in type 2 diabetic rats. Liu SZ; Sun D; Zhang GY; Wang L; Liu T; Sun Y; Li MX; Hu SY Chin Med J (Engl); 2012 Mar; 125(5):912-9. PubMed ID: 22490596 [TBL] [Abstract][Full Text] [Related]
9. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674 [TBL] [Abstract][Full Text] [Related]
10. Compared to Sleeve Gastrectomy, Duodenal-Jejunal Bypass with Sleeve Gastrectomy Gives Better Glycemic Control in T2DM Patients, with a Lower β-Cell Response and Similar Appetite Sensations: Mixed-Meal Study. Zachariah PJ; Chen CY; Lee WJ; Chen SC; Ser KH; Chen JC; Lee YC Obes Surg; 2016 Dec; 26(12):2862-2872. PubMed ID: 27138599 [TBL] [Abstract][Full Text] [Related]
11. Duodenal-Jejunal bypass improves glucose homeostasis in association with decreased proinflammatory response and activation of JNK in the liver and adipose tissue in a T2DM rat model. Hu C; Su Q; Li F; Zhang G; Sun D; Han H; Liu S; Hu S Obes Surg; 2014 Sep; 24(9):1453-62. PubMed ID: 24728905 [TBL] [Abstract][Full Text] [Related]
12. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model. Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544 [TBL] [Abstract][Full Text] [Related]
13. Duodenal-jejunal bypass improves glucose metabolism and adipokine expression independently of weight loss in a diabetic rat model. Hu C; Zhang G; Sun D; Han H; Hu S Obes Surg; 2013 Sep; 23(9):1436-44. PubMed ID: 23636998 [TBL] [Abstract][Full Text] [Related]
14. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients? de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376 [TBL] [Abstract][Full Text] [Related]
15. Effects of Duodenal-Jejunal Exclusion and New Bilio-Pancreatic Diversion on Blood Glucose in Rats with Type 2 Diabetes Mellitus. Weng SG; Zhang B; Wang X; Chen H Obes Surg; 2017 Aug; 27(8):2067-2072. PubMed ID: 28233263 [TBL] [Abstract][Full Text] [Related]
16. Roux-en-Y gastric bypass stands the test of time: 5-year results in low body mass index (30-35 kg/m(2)) Indian patients with type 2 diabetes mellitus. Lakdawala M; Shaikh S; Bandukwala S; Remedios C; Shah M; Bhasker AG Surg Obes Relat Dis; 2013; 9(3):370-8. PubMed ID: 23068107 [TBL] [Abstract][Full Text] [Related]
17. Duodenal-jejunal bypass for the treatment of type 2 diabetes in Chinese patients with an average body mass index<24 kg/m2. Jiang F; Zhu H; Zheng X; Tu J; Zhang W; Xie X Surg Obes Relat Dis; 2014; 10(4):641-6. PubMed ID: 24238729 [TBL] [Abstract][Full Text] [Related]
18. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes. Cohen RV; Neto MG; Correa JL; Sakai P; Martins B; Schiavon CA; Petry T; Salles JE; Mamedio C; Sorli C J Clin Endocrinol Metab; 2013 Feb; 98(2):E279-82. PubMed ID: 23337729 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of Sleeve Gastrectomy with Duodenal-Jejunal Bypass for the Treatment of Obese Severe Diabetes Patients in Japan: a Retrospective Multicenter Study. Naitoh T; Kasama K; Seki Y; Ohta M; Oshiro T; Sasaki A; Miyazaki Y; Yamaguchi T; Hayashi H; Imoto H; Tanaka N; Unno M Obes Surg; 2018 Feb; 28(2):497-505. PubMed ID: 28795271 [TBL] [Abstract][Full Text] [Related]
20. Duodenal-jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes. Jurowich CF; Rikkala PR; Thalheimer A; Wichelmann C; Seyfried F; Sander V; Kreissl M; Germer CT; Koepsell H; Otto C Ann Surg; 2013 Jul; 258(1):89-97. PubMed ID: 23478528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]